Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
First-in-class and unique reversal agent for ticagrelor aims to address important unmet need for patients requiring antiplatelet therapyPotential for accelerated development timeline with Phase 1...
-
MALVERN, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced...
-
MALVERN, Pa., April 25, 2017 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases...
-
MALVERN, Pa., March 29, 2017 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases...
-
MALVERN, Pa., Jan. 18, 2017 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases with...
-
First patients dosed in Part One, which is evaluating PB1046 in subjects with heart failurePart Two will examine PB1046 in subjects with cardiac dysfunction secondary to Duchenne muscular dystrophy;...
-
John S. Lee, M.D., Ph.D., named Chief Medical OfficerJohn P. Sharp, CPA, named Chief Financial Officer MALVERN, Pa., April 07, 2016 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a...
-
MALVERN, Pa., April 04, 2016 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company and leader in the field of biopolymer-based drugs, focused on developing...
-
Duke gains rights to ELP-small molecule conjugates in oncology PhaseBio retains rights to ELP technology in all other applications MALVERN, Pa., March 24, 2016 (GLOBE NEWSWIRE) -- PhaseBio...
-
MALVERN, Pa., March 04, 2016 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company and leader in the field of biopolymer-based drugs, focused on developing...